E N D
1. Acute myocardial infarction: Cardiac muscle necrosis secondary to protracted lack of coronary perfusion
Usual etiology: Thrombus at site of vascular injury
3. Other Etiologies of Acute Myocardial Infarction Coronary embolus
Coronary spasm
Coronary anomoly
Primary in situ thrombosis
Vasculitis
Hypotension
4. Determinants of Extent of Damage: Territory supplied
Duration of occlusion
Existence of collaterals
Oxygen demand at time of occlusion
Vasospasm
5. Presenting Symptoms of Acute MI Pain-
*typical-crushing substernal chest pain
*atypical - jaw, neck, shoulder, back pain, indigestion
*painless - silent
Dyspnea-
systolic and/or diastolic dysfunction
Dizziness-hypotension, arrhythmia
Nausea, vomiting
Elderly patients: Failure to thrive
Anxiety, restlessness, sense of impending doom
6. Presenting Signs in Acute MI Appearance: Pallor, diaphoretic, anxious
Vital Signs: Normal or abnormal BP and P
Hypertension and tachycardia: SNS
Hypotension and tachycardia:
Cardiogenic shock
Myocardial rupture
Tachyarrhythmia
Hypotension and bradycardia
vagal stimulation
Bradyarhythmia
7. Presenting Signs in Acute MI (Cont.) Lungs: Rales - CHF
Heart: Displaced LV impulse
S3
S4
Murmur of mitral regurgitation
Murmur of ventricular septal rupture
Pericardial rub
10. Natural History of Acute Myocardial Infarction Death-
Arrhythmia: VT/VF
Asystole
Myocardial rupture
Cardiogenic shock
Chronic Heart Disease -
LV dysfunction - remodeling
Papillary muscle dysfunction: MR
RV dysfunction
11. Natural History of Acute Myocardial Infarction, (Cont.) Stabilization ?compensated LV dysfunction
Post-infarction angina/ischemia (spontaneous or induced)
Recurrent MI
Post-infarction ventricular tachycardia
12. Treatment of Acute Myocardial Infarction: Acute Phase Prevent/resuscitate from sudden death: monitor, admit to CCU
Re-establish coronary flow
Thrombolytic therapy
Primary infarct angioplasty/stent
15. Major Contraindications To the Use of Thrombolytic Therapy Any previous history of hemorrhagic stroke
History of stroke, dementia, or central nervous system damage within 1 year
Head trauma or brain surgery within 6 months
Known intracranial neoplasm
Suspected aortic dissection
Internal bleeding within 6 weeks
Active bleeding or known bleeding disorder
Major surgery, trauma, or bleeding within 6 weeks
Traumatic cardiopulmonary resuscitation within 3 weeks
16. Treatment of acute MI: acute phase
Decrease myocardial oxygen demand
Pain relief/anxiolytics (Morphine sulfate)
Slow HR, control BP (beta blockers)
Increase myocardial oxygen supply
Oxygen
Prevent platelet aggregation/coronary thrombus propagation (aspirin, heparin)
Prevent spasm (nitrates)
Augment collateral flow (nitrates)
17. Treatment of Acute Myocardial Infarction: Acute Phase (Cont.) Stabilize plaques, restore endothelial function
? HMG CoA reductase inhibitors (statins)
Prevent ventricular remodeling
ACE inhibitors
Prevent mural thrombus/embolization
Heparin
Coumadin for anterior wall akinesis
18. Treatment of Acute Myocardial Infarction-Intermediate Phase Monitor/treat arrhythmias
Monitor/treat heart failure: systolic, diastolic, MR
Monitor/treat recurrent ischemia/infarction
Watch for pericarditis, Dresslers Syndrome
Monitor for myocardial rupture (free wall, VSD, MR)
Monitor for stroke
19. Determinants or Prognosis after Acute MI LV function (ejection fraction)
Inducible ischemia/coronary anatomy
Arrhythmia potential
20. Treatment of acute myocardial infarction: Pre-discharge Risk assessment
Is there LV systolic dysfunction?
Is there inducible ischemia?
Is there high risk coronary anatomy?
Is there VT/VF risk?
21. Tests for LV function Echocardiogram
Radionuclide ventriculogram (MUGA)
Contrast left ventriculogram (cath)
22. Echocardiogram in Acute Myocardial Infarction Wall motion abnormalities
Ejection fraction
Thrombus
Right ventricular MI
Papillary muscle dysfunction- mitral regurgitation
Free wall rupture/ventricular septal defect/papillary muscle rupture
23. Test for Inducible ischemia: Stress Test 1. Positive: Ischemic ST segment depression - ?1mm horizontal or downsloping ST depression
2. Negative: Patient reaches 85% maximum predicted heart rate (MPHR) without #1
3. Nondiagnostic: No ischemia but patient fails to reach 85% MPHR
27. Test to Define Coronary Anatomy: Coronary Angiogram Controversy: Should all patients undergo coronary angiogram after an MI?
Definite indications for coronary angiogram after MI:
Recurrent chest pain
Positive stress test
High risk features: CHF, low EF, prior MI
28. Risks of Coronary Angiography: (all are rare) Stroke
Myocardial infarction
Arrhythmia
Renal failure
Allergic reaction to contrast agent
29. Tests to Determine Arrhythmia Risk: Monitoring throughout hospitalization
Stress test
Electrophysiologic testing
Controversy: Who should undergo EP study after MI?
Sustained VT
Nonsustained VT with depressed ejection fraction
30. Treatment of Acute Myocardial Infarction Late Phase (Post-Hospital) Risk factor reduction:
Smoking
Hypertension
Diabetes
Dyslipidemia
Obesity/sedentary life style
Hyperhomocysteinemia
Stress/depression
Monitor for recurrent ischemia
Monitor for LV remodeling/CHF
31. ABCs of Treatment and Secondary Prevention of AMI Aspirin-prophylactic Rx for recurrent ischemic events; give for at least 3 mo. after AMI, probably indefinitely
Beta blockers-prophylactic, for reduction of cardiac mortality; Rx for 2 yr-indefinitely
Converting enzyme inhibitors-all pts with LV dysfunction to reduce risk of progressive heart failure and death.
Diet and lipid lowering Rx-statins have been shown to reduce risk of subsequent MI, need for revascularization and mortality (4S, Care)
Exercise and rehabilitation-essential in restoration of confidence and improvement in quality of life